JNK and p38 MAPK regulate oxidative stress and the inflammatory response in chlorpyrifos-induced apoptosis

Toxicology Letters

Volumn 218, Issue 3, 2013, Pages 235-245

  Ki, Yeo Woon ^a   Park, Jae Hyeon ^a   Lee, Jeong Eun ^a   Shin, In Chul ^a   Koh, Hyun Chul ^a  

^a Hanyang University   (South Korea)

Author keywords

Apoptosis; Chlorpyrifos; Cyclooxygenase 2; Mitogen activated protein kinase; Reactive oxidative species

Indexed keywords

BETA TUBULIN; CASPASE 3; CASPASE 9; CHLORPYRIFOS; CYCLOOXYGENASE 2; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TYROSINE 3 MONOOXYGENASE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CHLORPYRIFOS; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION MEDIATORS; INSECTICIDES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; TIME FACTORS;

EID: 84875276317     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.02.003     Document Type: Article

References (57)

1. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nature Medicine 2004, 10:18-25.
2. Bao W., Behm D.J., Nerurkar S.S., Ao Z., Bentley R., Mirabile R.C., Johns D.G., Woods T.N., Doe C.P., Coatney R.W., Ohlstein J.F., Douglas S.A., Willette R.N., Yue T.L. Effects of p38 MAPK inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. Journal of Cardiovascular Pharmacology 2007, 49:362-368.
3. Bezdecny S.A., Karmaus P., Roth R.A., Ganey P.E. 2,2',4,4'-Tetrachlorobiphenyl upregulates cyclooxygenase-2 in HL-60 cells via p38 mitogen-activated protein kinase and NF-kappaB. Toxicology and Applied Pharmacology 2007, 221:285-294.
4. Braughler J.M., Hall E.D. Central nervous system trauma and stroke, I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radical Biology and Medicine 1989, 6:289-301.
5. Carrasco E., Casper D., Werner P. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity. Journal of Neuroscience Research 2007, 85:3109-3117.
6. Caughlan A., Newhouse K., Namgung U., Xia Z. Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases. Toxicological Sciences 2004, 78:125-134.
7. Crumpton T.L., Seidler F.J., Slotkin T.A. Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos?. Brain Research. Developmental Brain Research 2000, 121:189-195.
8. Cui Y., Kim D.S., Park S.H., Yoon J.A., Kim S.K., Kwon S.B., Park K.C. Involvement of ERK AND p38 MAP kinase in AAPH-induced COX-2 expression in HaCaT cells. Chemistry and Physics of Lipids 2004, 129:43-52.
9. Dhingra S., Sharma A.K., Singla D.K., Singal P.K. p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. American Journal of Physiology. Heart and Circulatory Physiology 2007, 293:H3524-H3531.
10. Di Monte D.A. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?. Lancet Neurology 2003, 2:531-538.
11. Estevan C., Vilanova E., Sogorb M.A. Chlorpyrifos and its metabolites alter gene expression at non-cytotoxic concentrations in D3 mouse embryonic stem cells under in vitro differentiation: considerations for embryotoxic risk assessment. Toxicology Letters 2012, 217:14-22.
12. Farag A.T., El Okazy A.M., El-Aswed A.F. Developmental toxicity study of chlorpyrifos in rats. Reproductive Toxicology 2003, 17:203-208.
13. Geter D.R., Kan H.L., Lowe E.R., Rick D.L., Charles G.D., Gollapudi B.B., Mattsson J.L. Investigations of oxidative stress, antioxidant response, and protein binding in chlorpyrifos exposed rat neuronal PC12 cells. Toxicology Mechanisms and Methods 2008, 18:17-23.
14. Goodman L.R., Hansen D.J., Cripe G.M., Middaugh D.P., Moore J.C. A new early life-stage toxicity test using the California grunion (Leuresthes tenuis) and results with chlorpyrifos. Ecotoxicology and Environmental Safety 1985, 10:12-21.
15. Gupta R.C. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicology Mechanisms and Methods 2004, 14:103-143.
16. Gupta S.C., Mishra M., Sharma A., Deepak Balaji T.G., Kumar R., Mishra R.K., Chowdhuri D.K. Chlorpyrifos induces apoptosis and DNA damage in Drosophila through generation of reactive oxygen species. Ecotoxicology and Environmental Safety 2010, 73:1415-1423.
17. Han E.H., Kim J.Y., Kim H.K., Hwang Y.P., Jeong H.G. o,p'-DDT induces cyclooxygenase-2 gene expression in murine macrophages: role of AP-1 and CRE promoter elements and PI3-kinase/Akt/MAPK signaling pathways. Toxicology and Applied Pharmacology 2008, 233:333-342.
18. Hommes D.W., Peppelenbosch M.P., van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151.
19. Hsuan S.L., Klintworth H.M., Xia Z. Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways. Journal of Neuroscience 2006, 26:4481-4491.
20. Jang J.H., Surh Y.J. Beta-amyloid-induced apoptosis is associated with cyclooxygenase-2 up-regulation via the mitogen-activated protein kinase-NF-kappaB signaling pathway. Free Radical Biology and Medicine 2005, 38:1604-1613.
21. Jenner P., Olanow C.W. Understanding cell death in Parkinson's disease. Annals of Neurology 1998, 44:S72-S84.
22. Kaminska B., Gozdz A., Zawadzka M., Ellert-Miklaszewska A., Lipko M. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anatomical Record 2009, 292:1902-1913.
23. Karanth S., Pope C. Carbosylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicological Sciences 2000, 58:282-289.
24. Kim I.S., Ko H.M., Koppula S., Kim B.W., Choi D.K. Protective effect of Chrysanthemum indicum Linne against 1-methyl-4-phenylpridinium ion and lipopolysaccharide-induced cytotoxicity in cellular model of Parkinson's disease. Food and Chemical Toxicology 2011, 49:963-973.
25. Ku B.M., Lee Y.K., Jeong J.Y., Mun J., Han J.Y., Roh G.S., Kim H.J., Cho G.J., Choi W.S., Yi G.S., Kang S.S. Ethanol-induced oxidative stress is mediated by p38 MAPK pathway in mouse hippocampal cells. Neuroscience Letters 2007, 419:64-67.
26. Lee J., Kosaras B., Aleyasin H., Han J.A., Park D.S., Ratan R.R., Kowall N.W., Ferrante R.J., Lee S.W., Ryu H. Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response. FASEB Journal 2006, 20:2375-2377.
27. Lee J.E., Kang J.S., Ki Y.W., Lee S.H., Lee S.J., Lee K.S., Koh H.C. Akt/GSK3β signaling is involved in fipronil-induced apoptotic cell death of human neuroblastoma SH-SY5Y cells. Toxicology Letters 2011, 202:133-141.
28. Lee J.E., Park J.H., Shin I.C., Koh H.C. Reactive oxygen species regulated mitochondria-mediated apoptosis in PC12 cells exposed to chlorpyrifos. Toxicology and Applied Pharmacology 2012, 263:148-162.
29. Liang X., Wu L., Wang Q., Hand T., Bilak M., McCullough L., Andreasson K. Function of COX-2 and prostaglandins in neurological disease. Journal of Molecular Neuroscience 2007, 33:94-99.
30. Litteljohn D., Mangano E.N., Hayley S. Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice. European Journal of Neuroscience 2008, 28:707-716.
31. Madrigal J.L., Moro M.A., Lizasoain I., Lorenzo P., Fernández A.P., Rodrigo J., Boscá L., Leza J.C. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 2003, 28:1579-1588.
32. McCormack A.L., Thiruchelvam M., Manning-Bog A.B., Thiffault C., Langston J.W., Cory-Slechta D.A., Di Monte D.A. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiology of Disease 2002, 10:119-127.
33. McCubrey J.A., Lahair M.M., Franklin R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxidants & Redox Signalling 2006, 8:1775-1789.
34. Miettinen S., Fusco F.R., Yrjänheikki J., Keinänen R., Hirvonen T., Roivainen R., Närhi M., Hökfelt T., Koistinaho J. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:6500-6505.
35. Morno M., Cañadas F., Cardona D., Suñol C., Campa L., Sánchez-Amate M.C., Flores P., Sanchez-Santed F. Long-term monoamine changes in the striatum and nucleus accumbens after acute chlorpyrifos exposure. Toxicology Letters 2008, 176:162-167.
36. Moser V.C. Dose-response and time-course of neurobehavioral changes following oral chlorpyrifos in rats of different ages. Neurotoxicology and Teratology 2000, 22:713-723.
37. Newhouse K., Hsuan S.L., Chang S.H., Cai B., Wang Y., Xia Z. Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells. Toxicological Sciences 2004, 79:137-146.
38. Owen A.D., Schapira A.H., Jenner P., Marsden C.D. Oxidative stress and Parkinson's disease. Annals of the New York Academy of Sciences 1996, 786:217-223.
39. Park J.H., Lee J.E., Shin I.C., Koh H.C. Autophagy regulates chlorpyrifos-induced apoptosis in SH-SY5Y cells. Toxicology and Applied Pharmacology 2013, (Epub). 10.1016/j.taap.2013.01.013.
40. Perier J., Bové D.C., Wu D.C., Dehay B., Choi D.K., Jackson-Lewis V., Rathke-Hartlieb S., Bouillet P., Strasser A., Schulz J.B., Przedborski S., Vila M. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:8161-8166.
41. Quia D., Seidler F.J., Slotkin T.A. Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. Toxicology and Applied Pharmacology 2005, 206:17-26.
42. Ramsay R.R., Krueger M.J., Youngster S.K., Gluck M.R., Casida J.E., Singer T.P. Interaction of 1-methyl-4-phenylpyridinium ion (MPP) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. Journal of Neurochemistry 1991, 56:1184-1190.
43. Ranjbar A., Pasalar P., Abdollahi M. Induction of oxidative stress and acetylcholinesterase inhibition in organophosphorous pesticide manufacturing workers. Human and Experimental Toxicology 2002, 21:179-182.
44. Saulsbury M.D., Heyliger S.O., Wang K., Johnson D.J. Chlorpyrifos induces oxidative stress in oligodendrocyte progenitor cells. Toxicology 2004, 259:1-9.
45. Saulsbury M.D., Heyliger S.O., Wang K., Round D. Characterization of chlorpyrifos-induced apoptosis in placental cells. Toxicology 2008, 244:98-110.
46. Sherer T.B., Betarbet C.M., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. Journal of Neuroscience 2003, 23:10756-10764.
47. Teismann P., Vila M., Choi D.K., Tieu K., Wu D.C., Jacksonlewis V., Przedborski S. COX-2 and neurodegeneration in Parkinson's disease. Annals of the New York Academy of Sciences 2003, 991:272-277.
48. Vijitruth R., Liu M., Choi D.Y., Nguyen X.V., Hunter R.L., Bing G. Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. Journal of Neuroinflammation 2006, 3:1-16.
49. Wang Y., Zhang Y., Wei Z., Li H., Zhou H., Zhang Z., Zhang Z. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease. Journal of the Neurological Sciences 2009, 285:172-177.
50. Whitmarsh A.J. Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. Biochimica Biophysica Acta 2007, 1773:1285-1298.
51. Whitney K.D., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicology and Applied Pharmacology 1995, 134:53-62.
52. Yang T., Huang Y., Heasley L.E., Berl T., Schnermann J.B., Briggs J.P. MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells. Journal of Biological Chemistry 2000, 275:23281-23286.
53. Yang W., Tiffany-Castiglioni E., Lee M.Y., Son I.H. Paraquat induces cyclooxygenase-2 (COX-2) implicated toxicity in human neuroblastoma SH-SY5Y cells. Toxicology Letters 2010, 199:239-246.
54. Yu C., Rahmani M., Dent P., Grant S. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib. Experimental Cell Research 2004, 295:555-566.
55. Yu F., Wang Z., Ju B., Wang Y., Wang J., Bai D. Apoptotic effect of organophosphorus insecticide chlorpyrifos on mouse retina in vivo via oxidative stress and protection of combination of vitamins C and E. Experimental and Toxicologic Pathology 2008, 59:415-423.
56. Zhang Y., Dawson V.L., Dawson T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiology of Disease 2000, 7:240-250.
57. Zhou J.F., Xu G.B., Fang W.J. Relationship between acute organophosphorus pesticide poisoning and damages induced by free radicals. Biomedical and Environmental Sciences 2002, 15:177-186.